WEST HAVEN, CT--(Marketwire - October 05, 2007) - Everyone hates viruses. NanoViricides(OTCBB: NNVC) has found out a way to quickly respond to both emerging viral infections as well to established viruses. Their strategy is to destroy viruses in the bloodstream after infection utilizing drugs created by their nanotechnology-based platform drug development system. Market News First (www.mn1.com) has written a feature story investigating this interesting company and its “FluCide-I and FluCide-HP treatments for influenzas.”
